Brooke McLaughlin, MD, MPH, is a board-certified pediatrician, entrepreneur and fierce advocate for children with ADHD. She is the Founder and Principal Clinician at Birdrock Center for ADHD, an ADHD-focused private practice where she leads a strengths-based and multimodal approach to ADHD care. She is also a Faculty Affiliate of the Dartmouth Center for Technology and Behavioral Health where she continues her research studying parent and clinician perception of a novel ADHD support intervention for families (The ADHD Playbook).

Dr. McLaughlin completed her undergraduate work at Dartmouth College where she majored in Psychological and Brain Sciences and received the Dartmouth Lombard Service Fellowship to bring visibility to the needs of children with ADHD and learning disabilities. She subsequently earned her MD/MPH at Dartmouth Medical School and trained as a pediatrician at Dartmouth Hitchcock Medical Center. Additionally, she has been a member of the founding management team for two biotech start-ups, the most recent of which went public in 2021 (Compass Therapeutics). In her most recent role at Dartmouth Health, she bridged her interests in medicine, research and innovation as the Co-Founder of the ADHD Service at Dartmouth Hitchcock’s Lebanon Campus and offered a strengths-based and multimodal approach to ADHD care, serving hundreds of children and families from across NH and VT.

Dr. McLaughlin has also been recently supported with research funding from the Health Resources and Services Administration (HRSA) via the T32 mechanism and Dartmouth’s Community and Family Medicine Department where she led research exploring clinic-based and digital health tools to support parents and kids on their ADHD journey. She designed and developed The ADHD Playbook (a novel support tool for parents of children with ADHD) and is in the process of completing early acceptability and feasibility studies looking at the perception of parents and clinicians on Playbook use. Dr. McLaughlin has presented nationally and internationally on her current work and continues to look for innovative ways to bring kids with ADHD brains (and their families) state-of-the-art care, personalized guidance and unwavering support.

Dr. McLaughlin remains an intense optimist when it comes to reframing how kids with ADHD see themselves and how the world sees these children. As such, her current and future clinical, research and innovation work build on this strengths-based approach to supporting kids to thrive.

In her free time, Dr. McLaughlin loves to play the piano and to ski, run and do anything outdoors with her husband and three young children.